Efficacy of Botulinum Toxin Injections in the Rectus Femoris to Treat Stiff Knee Gait Following Acquired Brain Injury

NATerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

December 31, 2011

Conditions
Stiff Knee GaitBrain Injuries
Interventions
DRUG

placebo

A total of 2 cc sterile normal saline: will be injected in 0.5 cc aliquots into 4 different injectate sites within the rectus femoris (with EMG guidance) of the involved limb.

DRUG

botulinum toxin A (BTX-A)

200 Units BTX-A reconstituted with 2 cc sterile normal saline in 100:1 ratio. Teflon-coated EMG guidance for confirmation of injection into the Rectus femoris muscle in addition to utilizing standardized injection landmarks, the solution will be injected in 0.5 cc aliquots into 4 different injectate sites within the muscle.

Trial Locations (1)

49503

Mary Free Bed Rehabilitation Hospital, Grand Rapids

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Mary Free Bed Rehabilitation Hospital

OTHER